These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20854)

  • 1. Scleroderma-like changes in chronic graft vs host disease.
    Spielvogel RL; Goltz RW; Kersey JH
    Arch Dermatol; 1977 Oct; 113(10):1424-8. PubMed ID: 20854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: progressive systemic sclerosis-like syndrome after bone marrow transplantation. Clinical, immunologic, and pathologic findings.
    Herzog P; Clements PJ; Roberts NK; Furst DE; Johnson CE; Feig SA
    J Rheumatol; 1980; 7(1):56-64. PubMed ID: 6986468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic graft-versus-host reaction following bone marrow transplantation].
    Ippen H; Nagel G
    Hautarzt; 1984 Apr; 35(4):182-7. PubMed ID: 6373672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bullous sclerodermalike changes in chronic graft-vs-host disease.
    Hymes SR; Farmer ER; Burns WH; Morison WL; Tutschka PJ; Walters LL; Santos GW
    Arch Dermatol; 1985 Sep; 121(9):1189-92. PubMed ID: 3899019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo demonstration of microvascular pathology by intravital microscopy in experimental chronic graft-versus-host disease: analogy with scleroderma.
    Bos G; Majoor G; Slaaf D; Reneman R; van Breda Vriesman P
    J Rheumatol; 1988 Sep; 15(9):1339-45. PubMed ID: 3058970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similarity of scleroderma-like skin lesions in allogeneic and syngeneic bone marrow transplantation models.
    Bos GM; Majoor GD; Slaaf DW; van de Gaar MJ; Weijmer-van Velzen JS; van Breda Vriesman PJ
    Transplant Proc; 1989 Apr; 21(2):3262-3. PubMed ID: 2652812
    [No Abstract]   [Full Text] [Related]  

  • 7. Deposition of IgM and complement at the dermoepidermal junction in acute and chronic cutaneous graft-vs-host disease in man.
    Tsoi MS; Storb R; Jones E; Weiden PL; Shulman H; Witherspoon R; Atkinson K; Thomas ED
    J Immunol; 1978 May; 120(5):1485-92. PubMed ID: 26718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of antinuclear antibodies in scleroderma-like chronic graft-versus-host disease: clinical correlation and histocompatibility locus antigen association.
    Bell SA; Faust H; Mittermüller J; Kolb HJ; Meurer M
    Br J Dermatol; 1996 May; 134(5):848-54. PubMed ID: 8736324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome.
    Skert C; Patriarca F; Sperotto A; Cerno M; Filì C; Zaja F; Stocchi R; Geromin A; Damiani D; Fanin R
    Haematologica; 2006 Feb; 91(2):258-61. PubMed ID: 16461315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-vs-host reaction in skin: histological immunological and ultrastructural studies.
    Claudy AL; Schmitt D; Freycon F
    Acta Derm Venereol; 1979; 59(1):7-13. PubMed ID: 84472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rheumatologic manifestations of chronic graft vs host disease. 4 case reports].
    García López A; Parody Ruiz-Verdejo R; de la Iglesia Salgado JL; Povedano Gómez J; Albornoz López J
    Rev Clin Esp; 1999 Nov; 199(11):722-4. PubMed ID: 10638236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic cutaneous graft-versus-host disease in man.
    Shulman HM; Sale GE; Lerner KG; Barker EA; Weiden PL; Sullivan K; Gallucci B; Thomas ED; Storb R
    Am J Pathol; 1978 Jun; 91(3):545-70. PubMed ID: 26221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lichen planus like and sclerotic phases of the graft versus host disease in man: an ultrastructural study of six cases.
    Janin-Mercier A; Saurat JH; Bourges M; Sohier J; Jean LD; Gluckman E
    Acta Derm Venereol; 1981; 61(3):187-93. PubMed ID: 6167099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis.
    Owsianowski M; Gollnick H; Siegert W; Schwerdtfeger R; Orfanos CE
    Bone Marrow Transplant; 1994 Nov; 14(5):845-8. PubMed ID: 7889018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
    Vossen J
    Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models of scleroderma.
    Lakos G; Takagawa S; Varga J
    Methods Mol Med; 2004; 102():377-93. PubMed ID: 15286396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia.
    Champlin R; Giralt S; Przepiorka D; Ho W; Lee K; Gajewski J; Nimer S; Andersson B; Wallerstein R; Ippolito C
    Prog Clin Biol Res; 1992; 377():385-94; discussion 395-8. PubMed ID: 1438435
    [No Abstract]   [Full Text] [Related]  

  • 18. Is graft-versus-host disease a reliable model for scleroderma?
    Mekori YA; Claman HN
    Ric Clin Lab; 1986; 16(4):509-13. PubMed ID: 3576048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hepatic failure as onset of progressive sclerodermatous chronic graft-versus-host disease after donor lymphocyte infusion.
    Skert C; Patriarca F; Zaja F; Tomadini V; Fanin R
    Bone Marrow Transplant; 2005 Mar; 35(5):523-4. PubMed ID: 15654352
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma.
    McCormick LL; Zhang Y; Tootell E; Gilliam AC
    J Immunol; 1999 Nov; 163(10):5693-9. PubMed ID: 10553100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.